| Christopher L Nelson, ACNP-BC | |
|
310 S Penn St, Suite 105, Aberdeen, SD 57401-4553 | |
| (605) 622-8700 | |
| (605) 622-5056 |
| Full Name | Christopher L Nelson |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 310 S Penn St, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720376825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | CP000643 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Lukes | Aberdeen, SD | Hospital |
| Community Memorial Hospital | Redfield, SD | Hospital |
| Marshall County Healthcare Center - Cah | Britton, SD | Hospital |
| Faulkton Area Medical Center | Faulkton, SD | Hospital |
| Mobridge Regional Hospital - Cah | Mobridge, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
| Avera St Lukes | 6406764927 | 132 |
News Archive
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).
Adolescents who perform just eight to ten minutes of high-intensity interval exercise three times a week could be significantly reducing their risk of developing heart conditions, new research has concluded.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
› Verified 4 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).
Adolescents who perform just eight to ten minutes of high-intensity interval exercise three times a week could be significantly reducing their risk of developing heart conditions, new research has concluded.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
› Verified 4 days ago
| Entity Name | Avera St Lukes |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215100813 PECOS PAC ID: 6406764927 Enrollment ID: O20040120000912 |
News Archive
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).
Adolescents who perform just eight to ten minutes of high-intensity interval exercise three times a week could be significantly reducing their risk of developing heart conditions, new research has concluded.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher L Nelson, ACNP-BC Po Box 1460, Aberdeen, SD 57402-1460 Ph: (605) 622-8700 | Christopher L Nelson, ACNP-BC 310 S Penn St, Suite 105, Aberdeen, SD 57401-4553 Ph: (605) 622-8700 |
News Archive
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).
Adolescents who perform just eight to ten minutes of high-intensity interval exercise three times a week could be significantly reducing their risk of developing heart conditions, new research has concluded.
Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine in St. Louis.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced top line results from its randomized, double-blind, placebo-controlled, Phase 2b clinical trial of Synavive in rheumatoid arthritis.
› Verified 4 days ago
Ashley Marie Landis, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 8th Ave Nw, Suite A, Aberdeen, SD 57401 Phone: 605-226-2663 | |
Lindsay Habeck, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3015 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-226-5500 | |
Matthew R Lutjens, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 105 S State St Ste 113, Aberdeen, SD 57401 Phone: 605-225-0378 Fax: 605-225-7919 | |
Ms. Valerie Anne Jones, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1315 6th Ave Se, Suite 6, Aberdeen, SD 57401 Phone: 605-225-1538 Fax: 605-229-2053 | |
Kristine Lynn Fastenau, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 310 S Penn St Ste 203, Aberdeen, SD 57401 Phone: 605-225-7326 | |
Alisa Hogue, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 310 S Penn St, Suite 202, Aberdeen, SD 57401 Phone: 605-622-2895 Fax: 605-622-2896 | |
Sara Hegg, CNP, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2120 8th Ave Ne, Aberdeen, SD 57401 Phone: 605-725-4772 Fax: 605-725-4777 |